Antonina Mitrofanova

Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer

Min Zou, Roxanne Toivanen, Antonina Mitrofanova et al. · Cancer Discovery · 2017 · 394 citations · Full text

Medicine, Oncology, Pharmacology +17

Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy

Àlvaro Aytés, Antonina Mitrofanova, Céline Lefèbvre et al. · Cancer Cell · 2014 · 347 citations · Full text

Medicine, Molecular Biology, Oncology +16

Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity

Zhu A. Wang, Antonina Mitrofanova, Sarah K. Bergren et al. · Nature Cell Biology · 2013 · 309 citations

Life Sciences, Cell Biology, Oncology +17

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart et al. · Nature Cancer · 2021 · 241 citations · Full text

Medicine, Molecular Biology, Oncology +12

<i>ETV4</i> promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer

Àlvaro Aytés, Antonina Mitrofanova, Carolyn Waugh Kinkade et al. · Proceedings of the National Academy of Sciences · 2013 · 140 citations · Full text

Medicine, Molecular Biology, Oncology +17